OPTO

COM:OPTOMED

Optomed

  • Stock

Last Close

3.96

22/11 16:29

Market Cap

111.42M

Beta: -

Volume Today

29.47K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
1.33M
-
1.32M
1.01%
1.09M
17.50%
1.79M
64.78%
2.50M
39.51%
2.74M
9.35%
2.97M
8.38%
2.91M
1.95%
average payables
690K
-
595K
13.77%
627K
5.38%
1.20M
91.31%
1.13M
5.71%
769.50K
31.96%
906.50K
17.80%
2.21M
143.74%
average receivables
2.00M
-
872K
56.35%
1.44M
64.62%
4.00M
178.51%
2.56M
35.91%
3.88M
-
book value per share
0.27
-
0.09
66.99%
0.42
377.47%
2.53
501.89%
1.51
40.26%
1.27
16.18%
1.53
20.90%
1.22
20.54%
capex per share
-0.15
-
-0.15
0.84%
-0.13
11.92%
-0.16
24.69%
-0.14
14.50%
-0.19
39.47%
-0.23
19.26%
-0.14
36.78%
capex to depreciation
-2.56
-
-1.85
27.88%
-0.94
49.25%
-0.63
32.39%
-0.84
32.04%
-0.96
14.23%
-0.96
0.61%
-1.10
14.20%
capex to operating cash flow
2.36
-
2.52
6.63%
22.36
787.72%
-8.91
139.87%
0.65
107.29%
0.88
34.67%
1.28
45.98%
3.92
206.87%
capex to revenue
-0.29
-
-0.28
3.40%
-0.12
57.99%
-0.10
18.44%
-0.14
46.07%
-0.17
23.85%
-0.21
19.20%
-0.16
22.69%
cash per share
0.12
-
0.08
36.34%
0.15
93.80%
2.11
1,292.64%
0.80
62.12%
0.51
36.71%
0.64
26.97%
0.43
33.71%
days of inventory on hand
193.24
-
123.73
35.97%
82.59
33.25%
170.42
106.33%
219.97
29.08%
210.04
4.51%
200.86
4.37%
211.92
5.51%
days payables outstanding
81.55
-
61.11
25.06%
53.93
11.74%
115.11
113.43%
51.55
55.22%
67.53
31.01%
58.22
13.79%
266.78
358.22%
days sales outstanding
96.32
-
72.45
-
124.90
72.38%
77.11
-
debt to assets
0.39
-
0.38
3.58%
0.62
64.14%
0.54
13.65%
0.28
47.96%
0.25
10.81%
0.28
14.17%
0.22
24.10%
0.17
22.45%
debt to equity
1.00
-
1.08
8.04%
5.29
391.87%
2.04
61.45%
0.49
76.09%
0.38
21.09%
0.48
25.43%
0.33
31.33%
0.24
28.02%
dividend yield
earnings yield
-0.05
-
-0.05
4.68%
-0.02
56.08%
-0.05
141.82%
-0.03
34.62%
-0.03
2.78%
-0.11
241.54%
-0.07
34.43%
enterprise value
911K
-
62.59M
6,770.36%
65.54M
4.72%
69.75M
6.42%
48.83M
29.99%
92.87M
90.21%
133.15M
43.37%
47.89M
64.04%
59.22M
23.66%
enterprise value over ebitda
-32.86
-
-39.72
20.90%
50.84
227.98%
-154.03
402.99%
-125.00
18.85%
-137.84
10.27%
-38.28
72.23%
-45.48
18.82%
ev to operating cash flow
-77.27
-
-85.56
10.73%
-917.72
972.56%
303.27
133.05%
-33.16
110.93%
-45.29
36.59%
-20.21
55.39%
-96.29
376.56%
ev to sales
9.47
-
9.50
0.32%
4.82
49.24%
3.26
32.40%
7.14
118.95%
8.97
25.61%
3.27
63.57%
3.92
20.06%
free cash flow per share
-0.21
-
-0.20
1.03%
-0.13
34.14%
-0.14
5.96%
-0.35
144.43%
-0.41
17.71%
-0.41
0.77%
-0.18
55.49%
free cash flow yield
-0.05
-
-0.04
1.03%
-0.03
34.14%
-0.02
23.45%
-0.05
114.64%
-0.04
13.28%
-0.11
159.68%
-0.05
54.70%
graham net net
-0.21
-
-0.55
158.45%
-0.82
51.17%
0.78
194.61%
0.07
91.52%
-0.27
513.12%
-0.07
74.21%
0.13
287.00%
graham number
1.12
-
0.66
41.22%
0.95
44.81%
4.28
348.86%
2.86
33.31%
3.00
5.17%
3.77
25.62%
2.70
28.45%
income quality
0.29
-
0.27
9.66%
0.06
78.41%
-0.06
197.78%
0.88
1,674.37%
0.69
21.52%
0.43
37.40%
0.14
68.03%
intangibles to total assets
0.33
-
0.41
24.66%
0.50
23.50%
0.61
20.49%
0.32
47.17%
0.41
28.39%
0.45
9.02%
0.41
7.93%
0.47
14.74%
interest coverage
-29.34
-
-14.35
51.08%
-1.12
92.20%
-5.91
427.82%
-16.05
171.66%
-43.29
169.66%
-40.62
6.17%
-3.88
90.45%
interest debt per share
0.29
-
0.48
63.73%
0.90
87.70%
1.28
41.37%
0.60
53.40%
0.62
4.12%
0.52
16.58%
0.35
31.91%
inventory turnover
1.89
-
2.95
56.17%
4.42
49.81%
2.14
51.53%
1.66
22.53%
1.74
4.73%
1.82
4.57%
1.72
5.22%
invested capital
1.00
-
1.08
8.04%
5.29
391.87%
2.04
61.45%
0.49
76.09%
0.38
21.09%
0.48
25.43%
0.33
31.33%
0.24
28.02%
market cap
60.42M
-
60.42M
0%
60.42M
0%
56.65M
6.24%
95.76M
69.03%
131.73M
37.56%
49.67M
62.29%
61.48M
23.78%
net current asset value
384K
-
-1.56M
505.21%
-5.05M
224.42%
-9.07M
79.75%
8.49M
193.53%
5.78M
31.85%
2.42M
58.07%
5.13M
111.63%
4.41M
14.07%
net debt to ebitda
-1.14
-
-3.10
172.64%
6.80
318.99%
24.68
263.11%
3.88
84.28%
-1.48
138.07%
1.42
196.37%
1.74
21.92%
net income per share
-0.21
-
-0.22
4.68%
-0.10
56.08%
-0.32
234.74%
-0.24
25.55%
-0.32
31.96%
-0.41
30.52%
-0.27
35.57%
operating cash flow per share
-0.06
-
-0.06
5.43%
-0.01
90.08%
0.02
412.75%
-0.21
1,272.14%
-0.22
3.57%
-0.18
18.30%
-0.04
79.40%
payables turnover
4.48
-
5.97
33.45%
6.77
13.30%
3.17
53.15%
7.08
123.30%
5.40
23.67%
6.27
16.00%
1.37
78.18%
receivables turnover
3.79
-
5.04
-
2.92
41.99%
4.73
-
research and ddevelopement to revenue
0.08
-
0.03
59.12%
0.02
-
0.02
10.76%
0.03
30.79%
0.02
11.24%
0.02
38.14%
return on tangible assets
-0.46
-
-0.58
26.13%
-0.15
74.03%
-0.11
29.75%
-0.17
62.55%
-0.27
52.92%
-0.30
12.12%
-0.29
2.58%
revenue per share
0.50
-
0.52
4.39%
1.10
109.64%
1.68
52.88%
0.98
41.47%
1.10
12.62%
1.11
0.05%
0.90
18.23%
roe
-0.78
-
-2.48
217.09%
-0.23
90.80%
-0.13
44.39%
-0.16
24.63%
-0.25
57.44%
-0.27
7.95%
-0.22
18.92%
roic
-0.33
-
-0.36
7.17%
-0.04
89.21%
-0.06
61.11%
-0.09
49.69%
-0.16
74.98%
-0.16
0.48%
-0.15
9.40%
sales general and administrative to revenue
0.04
-
0.03
16.03%
0.03
-
0.05
63.07%
0.06
6.27%
0.05
10.52%
0.17
218.42%
shareholders equity per share
0.27
-
0.09
66.99%
0.42
377.47%
2.53
501.89%
1.51
40.26%
1.27
16.18%
1.53
20.90%
1.22
20.54%
stock based compensation to revenue
tangible asset value
642K
-
-555K
186.45%
-3.82M
588.11%
-7.24M
89.66%
9.98M
237.75%
7.32M
26.63%
4.08M
44.30%
7.45M
82.66%
6.62M
11.17%
tangible book value per share
-0.04
-
-0.29
588.11%
-0.55
89.66%
1.12
303.36%
0.55
50.57%
0.30
45.04%
0.56
85.12%
0.40
29.48%
working capital
3.88M
-
2.05M
47.30%
1.01M
50.83%
-3.97M
494.43%
17.90M
551.16%
13.29M
25.73%
9.46M
28.85%
10.86M
14.84%
8.08M
25.66%

All numbers in (except ratios and percentages)